Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy

Perfusion (United Kingdom)

Volumn 30, Issue 8, 2015, Pages 675-682

  Kalbhenn, J ^a   Wittau, N ^b   Schmutz, A ^a   Zieger, B ^a   Schmidt, R ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b St Josef's Hospital Freiburg   (Germany)

^c MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

ARDS; bleeding; coagulopathy; ECMO; factor XIII; fibrinogen; intracranial haemorrhage; von Willebrand syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 8 PLUS VON WILLEBRAND FACTOR; DESMOPRESSIN ACETATE; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; BLOOD CLOTTING FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN HEMORRHAGE; CENTRIFUGAL PUMP; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; FIBRINOGEN DEFECT; HUMAN; HYPOXIA; INCIDENCE; INTRAVASCULAR CATHETER; MALE; MORTALITY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; ADVERSE EFFECTS; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; CASE CONTROL STUDY; COMPARATIVE STUDY; GERMANY; HEMORRHAGE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VEIN; YOUNG ADULT;

ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GERMANY; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VEINS; YOUNG ADULT;

EID: 84945933484     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115579714     Document Type: Article

References (28)

1. Gattinoni L, Carlesso E, Langer T,. Clinical review: Extracorporeal membrane oxygenation. Crit Care 2011; 15: 243.
2. Combes A, Bacchetta M, Brodie D, Muller T, Pellegrino V,. Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care 2012; 18: 99-104.
3. Malagon I, Greenhalgh D,. Extracorporeal membrane oxygenation as an alternative to ventilation. Curr Opin Anaesthesiol 2013; 26: 47-52.
4. Zangrillo A, Landoni G, Biondi-Zoccai G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Critical care and resuscitation: Journal of the Australasian Academy of Critical Care Medicine 2013; 15: 172-178.
5. Kasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM,. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 1999; 15: 508-514.
6. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR, Registry E,. Extracorporeal Life Support Organization Registry Report 2012. ASAIO 2013; 59: 202-210.
7. Australia, New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza A Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302: 1888-1895.
8. Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S, Zieger B,. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb 2015; 22: 265-271.
9. Esper SA, Levy JH, Waters JH, Welsby IJ,. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion. Anesth Analg 2014; 118: 731-743.
10. Heilmann C, Geisen U, Beyersdorf F, et al. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 2011; 40: 1328-1333; discussion 1233.
11. Heilmann C, Geisen U, Beyersdorf F, et al. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 2012; 38: 62-68.
12. Ang AL, Teo D, Lim CH, Leou KK, Tien SL, Koh MB,. Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation-a single centre experience. Vox Sang 2009; 96: 34-43.
13. Le Gall JR, Lemeshow S, Saulnier F,. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
14. Gorlinger K, Bergmann L, Dirkmann D,. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012; 26: 179-198.
15. Plotz FB, van Oeveren W, Bartlett RH, Wildevuur CR,. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105: 823-832.
16. Mc Ilwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010; 90: 128-139.
17. Sorensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C,. Fibrinogen as a hemostatic agent. Semin Thromb Hemost 2012; 38: 268-273.
18. Korte W. F,. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010; 24: 85-93.
19. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H,. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33.
20. Lodemann P, Kolbeck H, Held TK, et al. Acquired deficiency of coagulation factor XIII-possible evidence for a new link between coagulation and infection from a case. Ann Hematol 2013; 92: 427-429.
21. Biswas A, Ivaskevicius V, Thomas A, Oldenburg J,. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Hamostaseologie 2014; 34: 160-166.
22. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009; 137: 208-215.
23. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56: 1207-1213.
24. Konkle BA,. Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program 2011; 2011: 391-396.
25. Pieri M, Turla O, Calabro M, et al. A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience. Perfusion 2013; 28: 132-137.
26. Baghai M, Tamura N, Beyersdorf F, et al. Platelet repellent properties of hydrogel coatings on polyurethane coated glass surfaces. ASAIO J 2014; 60: 587-593.
27. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care (The €Red Book€). ELSO, 2013.
28. Linneweber J, Dohmen PM, Kertzscher U, Affeld K, Nose Y, Konertz W,. The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps. Artif Organs 2007; 31: 345-351